02 julho 2020
Modeling the Future of COVID-19: Q&A with RAND Experts: The phrase “flatten the curve” familiarized millions of Americans with the type of epidemiological models used to estimate virus transmission, cases, and the potential death toll from COVID-19.
But those models may be less useful as the country enters a different stage of the crisis—one in which changed behaviors must be taken into account, and new policy questions about reopening need answers.
But those models may be less useful as the country enters a different stage of the crisis—one in which changed behaviors must be taken into account, and new policy questions about reopening need answers.
On the Clock and at Home: Post-COVID-19 Employee Monitoring in the Workplace: As companies take actions to ensure productivity, maintain protocols and protect workplace health, increased monitoring cannot be the end goal. HR professionals know this well, but the research suggests that many managers, supervisors and executives may not. The WFH shift triggered by COVID-19 has rapidly expanded deployment of potentially invasive tools and put them in the hands of reasonably inexperienced supervisors.
Organizations considering monitoring tools should have a robust discussion about what they are trying to achieve. Instituting monitoring without clear boundaries and goals risks privacy violations, additional work and a culture of surveillance.
Organizations considering monitoring tools should have a robust discussion about what they are trying to achieve. Instituting monitoring without clear boundaries and goals risks privacy violations, additional work and a culture of surveillance.
COVID-19: What are immunity passports and how would they work? Faced with deep recession, governments around the world are considering the use of immunity passports to allow a degree of normality to return.
Chile may be one of the first countries to put such a scheme into action. But the idea is proving controversial.
Inaccurate and insufficient testing could hamper ability to monitor immunity.
Chile may be one of the first countries to put such a scheme into action. But the idea is proving controversial.
Inaccurate and insufficient testing could hamper ability to monitor immunity.
Coronavirus contact tracing apps aren’t worth the health risk to Black and Latinx people: Given the current social climate — in which issues of inequity are cojoined with a public health crisis — we particularly push back on the unmitigated trust given to companies to assure us that they will not allow law enforcement to use contact tracing apps for punitive or surveillance purposes, even for apps that do not purport to disclose user identity and location. The stakes are too high, especially at a time when police involvement in the coronavirus pandemic response in Black communities is so much higher than in white communities.
US buys up world stock of key Covid-19 drug remdesivir: The US has bought up virtually all the stocks for the next three months of one of the two drugs proven to work against Covid-19, leaving none for the UK, Europe or most of the rest of the world.
01 julho 2020
The line is forming for a COVID-19 vaccine. Who should be at the front? the prioritization issue comes down to a tricky balancing act between best helping society versus protecting an individual’s health.
Subscrever:
Comentários (Atom)
-
The dangers of Covid-19 far outweigh the risks of a vaccine : So can I tell you that there won't be a long-term unknown side effect to t...
-
The Value of a Cure: An Asset Pricing Perspective : We provide an estimate of the value of a cure using the joint behavior of stock prices ...
-
The Oxford/AstraZeneca Vaccine Efficacy Data : We’re going to have to wait and collect more data to be able to say anything about these, fo...